Recent Trends in Treatment of Multidrug Resistant-Tuberculosis-A Review (original) (raw)

Profile image of hari prasathhari prasath

2017, Mycobacterial Diseases

visibility

description

6 pages

link

1 file

Guidelines for the management of drug-resistant tuberculosis

Jacques Grosset

Transactions of the Royal Society of Tropical Medicine and Hygiene, 1998

View PDFchevron_right

The joint Médecins Sans Frontières/Ministry of Health multidrug-resistant tuberculosis

Dilrabo ulmasova

2016

View PDFchevron_right

Emerging trends in tuberculosis therapy: A review

Pratik Oza

Journal of Scientific …, 2007

View PDFchevron_right

A Recent Review on Tuberculosis and Its Treatment

Kumud Upadhyaya

International journal of research in pharmacy and chemistry, 2019

View PDFchevron_right

WHO guidelines for the programmatic management of drug-resistant tuberculosis: 2011 update

H Getahun

European Respiratory Journal, 2011

View PDFchevron_right

New regimens for reducing the duration of treatment of drug-susceptible pulmonary tuberculosis

Marcus Conde

Drug Development Research, 2011

View PDFchevron_right

Tuberculosis: progress and advances in development of new drugs, treatment regimens, and host-directed therapies

Markus Maeurer

The Lancet Infectious Diseases, 2018

View PDFchevron_right

World Health Organization Group 5 Drugs for the Treatment of Drug-Resistant Tuberculosis: Unclear Efficacy or Untapped Potential?

Ekwaro OBUKU

Journal of Infectious Diseases, 2012

View PDFchevron_right

Extensively Drug-Resistant Tuberculosis, Pakistan

Babar Malik

Emerging Infectious Diseases, 2010

View PDFchevron_right

Old Drugs, New Purpose: Retooling Existing Drugs for Optimized Treatment of Resistant Tuberculosis

Ekwaro OBUKU

Clinical Infectious Diseases, 2012

View PDFchevron_right

Loading...

Loading Preview

Sorry, preview is currently unavailable. You can download the paper by clicking the button above.

Identification and Validation of Novel Drug Targets in Tuberculosis

Vinayak Singh

Current Pharmaceutical Design, 2004

View PDFchevron_right

New drugs and new regimens for the treatment of tuberculosis: review of the drug development pipeline and implications for national programmes

Andrew Vernon

Current Opinion in Pulmonary Medicine, 2010

View PDFchevron_right

A Review on Current Trends of Anti-Tubercular Drugs and Challenges in Eliminating Tuberculosis

Kaivalya Pillai

International Journal of Pharmacy and Pharmaceutical Research, 2020

View PDFchevron_right

Cross border, highly individualised treatment of a patient with challenging extensively drug-resistant tuberculosis

Henderik W . Frijlink

The European respiratory journal, 2018

View PDFchevron_right

High risk and rapid appearance of multidrug resistance during tuberculosis treatment in Moldova

Valeriu Crudu

European Respiratory Journal, 2014

View PDFchevron_right

Drug-resistant tuberculosis: A disease of target populations in Houston, Texas

Larry D Teeter

Journal of Infection, 2006

View PDFchevron_right

Morbidity rate of drug-susceptible tuberculosis and its medico-economic impact

Madiha Mushtaque

African Journal of Pharmacy and Pharmacology, 2020

View PDFchevron_right

Tuberculosis and multi-drug resistant tuberculosis: immunologic mechanisms and tools for controlling the disease

Margareth Dalcolmo

RECIIS, 2008

View PDFchevron_right

Identification of Different Factors Leading to the Development of Multidrug Resistance Tuberculosis

MUHAMMAD AIZAZ

Journal of Medicine, Physiology and Biophysics, 2017

View PDFchevron_right

Drug Resistant Pattern of M. tuberculosis -An Emerging Threat for Public Health

Taha Nazir

View PDFchevron_right

HIV Infection and Multidrug‐Resistant Tuberculosis—The Perfect Storm

Kenneth Castro

The Journal of Infectious Diseases, 2007

View PDFchevron_right

Review on Tuberculosis

Devansh K Mehta

View PDFchevron_right

Treatment of Latent Tuberculosis Infection in Patients Aged ≥35 Years

Andrea Cruz

Clinical Infectious Diseases, 2000

View PDFchevron_right

The Medical Research Council and treatments for tuberculosis before streptomycin

Linda Bryder

Journal of the Royal Society of Medicine, 2014

View PDFchevron_right

Updating the approaches to define susceptibility and resistance to anti-tuberculosis agents: implications for diagnosis and treatment

Miguel Viveiros

European Respiratory Journal

View PDFchevron_right

Drug resistance pattern of M. tuberculosis in category II treatment failure pulmonary tuberculosis patients

Fahmida Sharmeen Rahman

Ibrahim Medical College Journal, 2014

View PDFchevron_right

Extensively Drug-Resistant Tuberculosis in the United States, 1993-2007

Ibrahim Abubakar

JAMA, 2008

View PDFchevron_right

Tuberculosis; Relapse in Interrupted Antituberculous Therapy

Muhammad Abdur Rehman khadam, Awais Iqbal

THE PROFESSIONAL MEDICAL JOURNAL, 2017

View PDFchevron_right

Drug resistance in tuberculosis control. A global and Indian situation

Harshad Thakur

MEDICINE, 2008

View PDFchevron_right

Treatment Outcomes of Short Course Regimens for Multidrug-Resistant Tuberculosis patients in Peshawar

syed muhammad Nasir

Pakistan Journal of Chest medicine, 2020

View PDFchevron_right

The Peculiarities of the Patients with Mono-Resistant and Poly-Resistant Tuberculosis

Niguleanu Adriana

Zenodo (CERN European Organization for Nuclear Research), 2022

View PDFchevron_right

Resistance patterns and trends of extensively drug-resistant tuberculosis: 5-year experience

Amresh Singh

Journal of Microbiology and Infectious Diseases, 2013

View PDFchevron_right

4th National Anti-tuberculosis Drug Resistance Survey in Kenya

Jane Mwangi

J. of Health Science, 2017

View PDFchevron_right

Outcomes of Multidrug-Resistant Tuberculosis among Binational Cases in El Paso, Texas

priyanka boppe

American Journal of Tropical Medicine and Hygiene, 2010

View PDFchevron_right

Efficacy and Safety of a 4-Drug Fixed-Dose Combination Regimen Compared With Separate Drugs for Treatment of Pulmonary Tuberculosis

noureddine Zidouni

JAMA, 2011

View PDFchevron_right

Mycobacterial DiseasesOmics